Entropy Technologies LP Has $3.43 Million Stock Position in Veeva Systems Inc. $VEEV

Entropy Technologies LP reduced its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 35.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 19,503 shares of the technology company’s stock after selling 10,743 shares during the period. Entropy Technologies LP’s holdings in Veeva Systems were worth $3,426,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of VEEV. Bridgewater Advisors Inc. lifted its holdings in shares of Veeva Systems by 129.2% in the first quarter. Bridgewater Advisors Inc. now owns 2,239 shares of the technology company’s stock worth $393,000 after acquiring an additional 1,262 shares during the last quarter. GC Wealth Management RIA LLC grew its holdings in shares of Veeva Systems by 3.9% during the 1st quarter. GC Wealth Management RIA LLC now owns 1,936 shares of the technology company’s stock valued at $340,000 after purchasing an additional 73 shares during the last quarter. Public Employees Retirement System of Ohio grew its holdings in shares of Veeva Systems by 8.3% during the 1st quarter. Public Employees Retirement System of Ohio now owns 71,412 shares of the technology company’s stock valued at $12,544,000 after purchasing an additional 5,500 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Veeva Systems by 203.0% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock worth $160,427,000 after purchasing an additional 611,868 shares in the last quarter. Finally, Inceptionr LLC acquired a new position in Veeva Systems during the 1st quarter worth approximately $1,591,000. 88.20% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Guggenheim upgraded Veeva Systems to strong-buy and later set a $232 price target, implying meaningful upside from current levels. Tickerreport.com
• Positive Sentiment: Investor interest is being supported by articles highlighting Veeva as a cash-heavy stock with financial stability, which may appeal to defensive growth investors. Yahoo Finance
• Positive Sentiment: Recent commentary points to steady execution and attractive P/E multiples, reinforcing the view that Veeva’s fundamentals remain solid ahead of its next earnings report. Seeking Alpha
• Neutral Sentiment: Several recent articles focus on what to expect from Veeva’s next earnings release and broader analyst sentiment, suggesting the stock may remain sensitive to upcoming guidance and results. MSN
• Negative Sentiment: The stock had recently declined more than the broader market, reminding investors that near-term volatility remains a risk despite the positive analyst coverage. Yahoo Finance

Insider Buying and Selling

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the transaction, the director directly owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. The trade was a 18.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Robert W. Baird boosted their target price on shares of Veeva Systems from $250.00 to $260.00 and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Guggenheim assumed coverage on Veeva Systems in a research note on Thursday. They issued a “buy” rating and a $232.00 price target for the company. Wall Street Zen raised Veeva Systems from a “hold” rating to a “buy” rating in a report on Sunday. The Goldman Sachs Group reduced their price objective on Veeva Systems from $190.00 to $165.00 and set a “sell” rating on the stock in a research report on Thursday, June 4th. Finally, Canaccord Genuity Group dropped their target price on Veeva Systems from $235.00 to $220.00 and set a “hold” rating for the company in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $247.08.

Veeva Systems Stock Performance

VEEV stock opened at $186.06 on Friday. The company has a fifty day moving average price of $174.59 and a 200-day moving average price of $181.60. The company has a market capitalization of $30.22 billion, a P/E ratio of 33.17, a PEG ratio of 0.80 and a beta of 0.94. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The company had revenue of $882.95 million for the quarter, compared to analyst estimates of $857.73 million. During the same quarter in the previous year, the business earned $1.97 earnings per share. Veeva Systems’s revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts forecast that Veeva Systems Inc. will post 6.65 earnings per share for the current fiscal year.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.